Cardiovascular Care

Specialist Cardiovascular Care for Patients with Diabetes, Kidney Disease, and Complex Systemic Conditions

Advanced cardiovascular assessment, diagnostic evaluation, and catheter-based intervention for patients with diabetes, chronic kidney disease, end-stage renal disease, and multi-system cardiovascular risk.

Standard cardiovascular pathways are frequently inadequate for these populations. Safe and effective care requires subspecialty-level expertise, a precision-guided procedural approach, and a deep understanding of how cardiovascular and systemic disease interact.

Why These Patients Require Specialist Care?

Patients with diabetes, chronic kidney disease, or multiple coexisting medical conditions represent some of the highest-risk and most underserved groups in cardiovascular medicine. Their coronary disease is characteristically more diffuse, more heavily calcified, and more anatomically complex. Their physiology makes procedural complications more likely. And the contrast dye used in standard coronary procedures is directly toxic to the kidneys, posing a risk of acute kidney injury that in patients with already-compromised renal function can accelerate progression to dialysis or cause irreversible damage.

The consequences of failing to account for these factors include unnecessary interventions, contrast-induced kidney injury, inadequate calcium modification leading to early stent failure, and the denial of effective treatment to patients considered too high-risk by conventional standards.

This practice has dedicated both clinical expertise and academic research to this patient population, with specific focus on safe coronary intervention in patients with renal impairment and complex systemic disease.

Heart and Kidney Connection
Cholesterol Management | Interventional Cardiology

Conditions Treated

Diabetes-Associated Coronary Artery Disease

Coronary disease in diabetes is often diffuse, calcified, and multivessel, requiring detailed imaging and physiological assessment to guide treatment and optimise stent delivery.

End-Stage Renal Disease on Dialysis

Dialysis-dependent patients face very high cardiovascular mortality, but careful planning and zero-contrast techniques enable safe, effective coronary intervention.

High-Risk Coronary Disease with Systemic Comorbidity

Complex coronary anatomy with renal disease, diabetes, heart failure, or respiratory disease requires careful planning, physiological assessment, and kidney-protective strategies.

Chronic Kidney Disease and Cardiovascular Complications

Chronic kidney disease accelerates coronary artery disease and arterial calcification while increasing the risk of contrast-related kidney injury during coronary procedures.

Pre-Transplant Cardiovascular Assessment

Patients awaiting renal, liver, or multi-organ transplantation require cardiovascular assessment to identify and treat cardiac disease before surgery.

Resistant Hypertension with End-Organ Damage

Uncontrolled hypertension can progressively damage the heart and kidneys, requiring specialist evaluation to identify the cause and exclude secondary conditions such as renal artery stenosis.

Advanced REnal Diagnostic Assessment

Advanced Diagnostic Assessment

Intracoronary Physiology (FFR and iFR)

In patients with diffuse multivessel disease, physiological testing identifies which narrowings are truly limiting blood flow and therefore which lesions warrant treatment. In the context of diabetes and renal disease, where the consequences of both unnecessary and incomplete treatment are amplified, physiology-guided decision-making is particularly important.

Comprehensive Cardiovascular Risk Profiling

Integrated review of clinical history, comorbidity burden, renal function, metabolic profile, and prior investigations to define overall cardiovascular risk and identify the safest diagnostic and treatment pathway for each patient.

Intracoronary Imaging (IVUS and OCT)

High-resolution imaging of the coronary artery wall is fundamental to managing calcified disease in diabetic and renal patients. In zero-contrast procedures, IVUS co-registration replaces angiographic guidance entirely, enabling safe and precise stent implantation without contrast exposure.

Kidney-Sparing Diagnostic Strategy

Contrast volume is carefully minimised during all coronary procedures in patients with renal impairment, using pre-procedural hydration, strict contrast dose limitation, and in selected cases IVUS co-registration to obtain diagnostic information without contrast exposure.

Procedures Performed

Ultra-Low Contrast PCI

Coronary intervention in which contrast volume is reduced to a fraction of the standard amount, using IVUS co-registration to guide vessel sizing and stent deployment while substantially reducing the risk of kidney injury.

Zero Contrast PCI

Coronary intervention performed without any iodinated contrast, guided entirely by intracoronary imaging and physiological assessment. Reserved for patients at highest risk of contrast-induced renal injury, including those with end-stage renal disease. Pioneered in the UAE and published in the Journal of Invasive Cardiology.

IVUS-Guided Coronary Intervention

Stent implantation guided in real time by intravascular ultrasound, enabling accurate vessel sizing, calcium identification, confirmation of complete stent expansion, and assessment of final stent position.

Physiology-Guided Revascularisation

Treatment limited to lesions confirmed by pressure wire assessment to be haemodynamically significant, reducing procedural risk, contrast exposure, and medication burden in patients with multi-vessel disease and significant comorbidities.

Rotational Atherectomy, Orbital Atherectomy, and Intravascular Lithotripsy

Calcium modification techniques applied to the heavily calcified lesions disproportionately prevalent in diabetic and renal patients. All three are performed at Level 3 independent competence.

Renal Artery Angiography and Stenting

Catheter-based assessment and treatment of renal artery stenosis as a contributing cause of resistant hypertension or progressive renal impairment.

WHY CHOOSE DR. YASIR PARVIZ

International Expertise. Precision Cardiovascular Care.

Dr. Yasir Parviz has specialist experience managing coronary disease in patients with diabetes, kidney disease, and multiple medical conditions. His approach combines careful risk assessment, intracoronary imaging, and kidney-protective techniques to make complex cardiovascular treatment safer and more precise.

Kidney-Protective Coronary Care

Minimal and Zero-Contrast PCI

Complex High-Risk Intervention

Physiology and Imaging Guidance

Frequently Asked Questions

1. Can coronary procedures harm kidney function?
Iodinated contrast dye used in standard coronary procedures is nephrotoxic and can cause acute kidney injury in patients with pre-existing renal impairment. Ultra-low and zero-contrast techniques substantially reduce or eliminate this risk, enabling safe coronary procedures in patients who would previously have been considered too high-risk.
2. What is zero-contrast PCI?
Zero-contrast PCI is a catheter-based coronary intervention performed without iodinated contrast, guided entirely by intracoronary imaging and physiological assessment. It is indicated for patients with end-stage renal disease or severely reduced kidney function in whom standard contrast volumes would carry an unacceptable risk of further kidney injury.
3. Why is coronary artery disease more complex in patients with diabetes?
Diabetes accelerates and amplifies atherosclerosis, producing coronary disease that is more diffuse, more heavily calcified, and more often involving multiple vessels simultaneously. It also impairs the healing response after stenting, increasing the risk of restenosis. These factors make diagnosis more challenging and intervention technically more demanding.
4. Can patients on dialysis have coronary intervention safely?
Yes, with appropriate planning and specialist techniques. Dialysis-dependent patients can undergo coronary angiography and PCI safely when zero-contrast approaches are used, lesion selection is guided by physiology, and calcium modification is applied where needed. The key is careful patient selection and precision-guided procedural planning.
5. Why is cardiac assessment important before transplant surgery?
Transplantation places significant physiological stress on the cardiovascular system. Unidentified or undertreated coronary artery disease is a leading cause of adverse cardiac events around the time of surgery. Pre-transplant cardiovascular assessment identifies patients who require coronary intervention or optimised medical treatment before they proceed, substantially reducing cardiac risk.
6. Is it safe to have a coronary angiogram if my kidneys are already compromised?
With a kidney-protective strategy in place, coronary angiography can be performed safely in most patients with renal impairment. Contrast volume is minimised, hydration protocols are used, and in high-risk cases IVUS co-registration allows diagnostic information to be obtained with little or no contrast. Each patient's renal risk is assessed individually before any procedure is planned.